939 related articles for article (PubMed ID: 15533351)
1. Add-back therapy in the treatment of endometriosis-associated pain.
Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
[TBL] [Abstract][Full Text] [Related]
2. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
Sesti F; Pietropolli A; Capozzolo T; Broccoli P; Pierangeli S; Bollea MR; Piccione E
Fertil Steril; 2007 Dec; 88(6):1541-7. PubMed ID: 17434511
[TBL] [Abstract][Full Text] [Related]
3. Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain.
Al-Azemi M; Jones G; Sirkeci F; Walters S; Houdmont M; Ledger W
BJOG; 2009 Nov; 116(12):1646-56. PubMed ID: 19735378
[TBL] [Abstract][Full Text] [Related]
4. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.
Harada T; Momoeda M; Taketani Y; Hoshiai H; Terakawa N
Fertil Steril; 2008 Nov; 90(5):1583-8. PubMed ID: 18164001
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
[TBL] [Abstract][Full Text] [Related]
6. Current approaches to optimizing the treatment of endometriosis in adolescents.
Laufer MR
Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
[TBL] [Abstract][Full Text] [Related]
7. Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment.
Szendei G; Hernádi Z; Dévényi N; Csapó Z
Gynecol Endocrinol; 2005 Aug; 21(2):93-100. PubMed ID: 16109595
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of endometriosis in private practice: cohort study with mean follow-up of 3 years.
Roman JD
J Minim Invasive Gynecol; 2010; 17(1):42-6. PubMed ID: 20129331
[TBL] [Abstract][Full Text] [Related]
9. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial.
Seracchioli R; Mabrouk M; Frascà C; Manuzzi L; Savelli L; Venturoli S
Fertil Steril; 2010 Jul; 94(2):464-71. PubMed ID: 19442968
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Morris EP; Rymer J; Robinson J; Fogelman I
Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
[TBL] [Abstract][Full Text] [Related]
12. Pain of endometriosis: effects of nafarelin and danazol therapy.
Adamson GD; Kwei L; Edgren RA
Int J Fertil Menopausal Stud; 1994; 39(4):215-7. PubMed ID: 7951404
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis.
Wu D; Hu M; Hong L; Hong S; Ding W; Min J; Fang G; Guo W
Arch Gynecol Obstet; 2014 Sep; 290(3):513-23. PubMed ID: 24728145
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
16. [A meta-analysis of preventing bone mineral loss in patients with endometriosis treated by gonadotrophin-releasing hormone analogues with add-back therapy].
Niu ZR; Yue XJ; Kong QY; Wang YF; Yao YQ
Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):338-43. PubMed ID: 24016475
[TBL] [Abstract][Full Text] [Related]
17. [GnRH agonist and add back therapy--indications, results and problems in the treatment of genital endometriosis].
Mettler L
Zentralbl Gynakol; 2003; 125(7-8):267-75. PubMed ID: 14505262
[TBL] [Abstract][Full Text] [Related]
18. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis.
Ferrero S; Camerini G; Seracchioli R; Ragni N; Venturini PL; Remorgida V
Hum Reprod; 2009 Dec; 24(12):3033-41. PubMed ID: 19726448
[TBL] [Abstract][Full Text] [Related]
19. Anastrazole and oral contraceptives: a novel treatment for endometriosis.
Amsterdam LL; Gentry W; Jobanputra S; Wolf M; Rubin SD; Bulun SE
Fertil Steril; 2005 Aug; 84(2):300-4. PubMed ID: 16084868
[TBL] [Abstract][Full Text] [Related]
20. Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy.
Heinrichs WL; Henzl MR
J Reprod Med; 1998 Mar; 43(3 Suppl):299-308. PubMed ID: 9564665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
